Guidewire to Acquire hyperexponential in Deal Worth Up to $2.1 Billion to Expand AI Underwriting

Guidewire Software (NYSE: GWRE) has agreed to acquire London-based underwriting technology company hyperexponential in a transaction valued at up to approximately $2.1 billion, according to MarketBeat. The deal combines a base cash purchase price of $1.7 billion with up to $400 million in additional contingent consideration tied to revenue targets, as reported by Morningstar and Central Oregon Daily.

hyperexponential, often referred to as "hx," makes AI-powered underwriting and pricing software for commercial property and casualty insurers, per Morningstar's reporting of the companies' announcement. The company was already an existing Guidewire PartnerConnect Technology Alliance Partner before the acquisition was announced, according to Morningstar, with Insurance Business Magazine also noting hx was already a Guidewire technology partner.

Deal Terms and Strategic Rationale

Guidewire is framing the acquisition as a move to lead what it calls the transformation to "agentic underwriting," a model in which AI agents assess, price and make decisions alongside human underwriters and actuaries across commercial and specialty insurance lines, according to Morningstar's account of the deal announcement. Guidewire CEO Mike Rosenbaum said on a call discussing the deal, as quoted by MarketBeat, that "today's acquisition is about delivering that new agentic underwriting platform," calling it "a commitment by Guidewire to lead the transformation to agentic underwriting across every segment and line of business in commercial insurance."

Rosenbaum also said Guidewire sees an emerging $30 billion market opportunity in underwriting transformation, MarketBeat reported. He described Guidewire's existing pricing and rating capabilities as better suited to more defined, flow-based commercial business, while hyperexponential has focused on complex risks where actuaries and underwriters work more closely on customized pricing and risk decisions, according to MarketBeat's summary of his remarks.

What hyperexponential Brings to Guidewire's Platform

hyperexponential's platform has powered underwriting decisions across more than $75 billion in annual commercial P&C premium for global insurers, reinsurers and managing general agents, Morningstar reported, citing customers including Aviva, Allianz, Sompo, Beazley, Markel, HDI, Cincinnati Financial, Convex and Bowhead. The company brings nearly 300 employees and experience in the London specialty market, according to MarketBeat and Insurance Business Magazine. By comparison, Guidewire's own software is used by more than 570 P&C insurers in 44 countries, supported by more than 1,700 implementation projects, per Central Oregon Daily and Insurance Business Magazine.

Guidewire expects the acquisition to contribute at least 650 basis points to fiscal year 2027 annual recurring revenue (ARR) growth on an inorganic basis, and at least 150 basis points to durable organic ARR growth starting in fiscal 2028, Morningstar reported, a figure CFO Jeff Cooper reiterated on the deal call per MarketBeat. Cooper said those growth assumptions are based largely on the two companies' standalone plans rather than anticipated synergies, adding that integration synergies "could provide upside" to the disclosed figures, according to MarketBeat.

Also notable: Guidewire co-founder and former CEO Marcus Ryu joined hyperexponential's board when Battery Ventures led the insurtech's $73 million Series B funding round in 2024, Insurance Business Magazine reported. Earlier backers included Highland Europe, which led an $18 million Series A in 2021, and a16z, which joined the Series B, according to a post from Traded: Venture Capital on X.

Financing and What It Means for Guidewire's Balance Sheet

Guidewire plans to fund the acquisition through roughly $1 billion in new Term Loan A financing plus existing cash on hand, according to Morningstar and Central Oregon Daily. The company has secured a binding debt commitment for the loan from Bank of America, N.A. and Citibank, N.A., Morningstar reported. Beyond those details, the available reporting does not specify how the new term loan will affect Guidewire's existing debt levels or leverage ratios; Morningstar's account states only that the term loan and cash on hand will be used together to fund the transaction. Guidewire said it will provide updated second-quarter and full-year fiscal 2027 guidance on its next earnings call in December 2026, per Morningstar.

Timeline, Approvals and Open Questions

Guidewire expects the transaction to close in its second fiscal quarter, ending January 31, 2027, subject to what MarketBeat described only as "customary closing conditions." The available reporting does not name specific regulatory approvals, such as antitrust filings, required before closing. Guidewire's own forward-looking risk disclosure, cited by Morningstar, flags uncertainty over whether the transaction and its funding will be completed on a timely basis or at all, and notes the deal "may involve unexpected costs, liabilities, or delays."

Centerview Partners is serving as exclusive financial advisor and Latham & Watkins LLP as legal counsel to Guidewire; J.P. Morgan is serving as exclusive financial advisor and Wilson Sonsini Goodrich & Rosati (UK) LLP as legal counsel to hyperexponential, Morningstar reported.

Industry coverage from Insurance Business Magazine raised open questions for existing hyperexponential customers, including whether Guidewire will maintain support for hx's existing integration with competing core system Duck Creek, and how responsibility for underwriting decisions will be split between AI software and human underwriters. That report notes the announcement does not say whether Guidewire ownership will change support for Duck Creek-linked customers.

Share Price Context

Guidewire shares closed at $171.44 on October 19, rising to $189.64 by October 22, according to recorded closing-price data. That move works out to a gain of $18.20, or roughly 10.6% (calculated as (189.64-171.44)/171.44 x 100; our calculation), over that span. Shares then eased to $183.96 by the October 26 close, a decline of $5.68, or about 3.0%, from the October 22 level (calculated as (183.96-189.64)/189.64 x 100; our calculation). The available price data runs only through October 26, the trading session before the acquisition was reported on October 27, so it does not capture how shares moved in direct response to the announcement itself.

Bottom Line

Guidewire's agreement to acquire hyperexponential for up to $2.1 billion marks a significant push into AI-driven underwriting for commercial and specialty insurance lines, adding a team of nearly 300 employees with ties to the London specialty market and a platform that, per Morningstar, has powered underwriting decisions across more than $75 billion in annual commercial P&C premium. The company is funding the deal with roughly $1 billion in new term loan financing plus cash on hand, and CFO Jeff Cooper said the disclosed ARR growth targets rest largely on the two companies' standalone plans, with integration synergies potentially providing upside, according to MarketBeat. Investors should get more clarity on updated guidance when Guidewire holds its next earnings call in December 2026, with the deal expected to close by the end of its fiscal second quarter in January 2027, subject to customary closing conditions.